CoChat

Hepato-Incretin Function of GLP-1: Novel Concept and Target in Type 1 Diabetes

Ahrén, Bo · 2015 · Diabetes

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

The liver is a key player in glucose regulation, and several factors are involved in this regulation (1). Glucagon, au-tonomic nerves, and the adrenals stimulate hepatic glu-cose production to allow sufficient brain glucose delivery. Insulin inhibits hepatic glucose production, preventing excess hepatic glucose release. This is of particular impor-tance after meals, as is evident from the negative corre-lation between early insulin response after meals and postprandial glucose (2). Therefore, low insulin and high glucagon levels—such as observed in type 1 and type 2 diabetes—sustain liver glucose production, thereby result-ing in postprandial and fasting hyperglycemia. Thus, re-ducing hepatic glucose production is an important target in the treatment of diabetes (3). The incretin hormone GLP-1 inhibits hepatic glucose

Overview

Integrity signals

Registry

Crossref · 10.2337/db14-1671

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 16

Metadata

Authors
Ahrén, B.
Affiliations
Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Lund, Sweden
Venue
Diabetes
Published
2015-02-17
Volume
64
Issue
3
Pages
715-717
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2159326211
Cited by
13
References
20
Citations by year
2025: 2 · 2024: 3 · 2020: 1 · 2019: 1 · 2017: 2 · 2016: 1 · 2015: 3
FWCI
1.73
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes (publishedVersion)
  • PubMed (publishedVersion)
  • Lund University Publications (Lund University) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
glucagon-like peptide-1, hepatic glucose production, type 1 diabetes, incretins, glucagon, insulin, postprandial hyperglycemia
MeSH terms
Glucagon-Like Peptide-1 Receptor, Animals, Glucagon, Glucose, Insulin, Receptors, Glucagon

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.